The BIO International Convention, the world's largest gathering in the biotechnology and pharmaceutical industries, is currently underway in Boston, USA. The event brings together approximately 20,000 attendees and 1,400 exhibitors from around the globe, providing a platform for companies to showcase their advancements and forge valuable collaborations.

Representing the Czech Republic at the national booth organized by the Ministry of Trade and Industry, six companies are highlighting successful Czech ideas in the fields of pharmaceuticals, biomedical research, artificial intelligence, and technology transfer. Among them is IOCB Tech, a subsidiary of the Institute of Organic Chemistry and Biochemistry located in Prague, Czech Republic, specializing in technology transfer.

Rudolf Klepáček, Director of the Export Support Department at the Ministry of Industry and Trade, emphasizes the importance of events like BIO International in facilitating science-business collaborations. He states, "Czech science and industry have earned an excellent reputation worldwide. However, without proper support and promotion, even the most promising projects may struggle to materialize. BIO International offers significant opportunities for Czech companies to establish crucial partnerships and succeed in the global market."

In addition to IOCB Tech, other Czech companies showcasing their expertise at the event include AbCheck, focusing on new drug development; Apigenex, a chemical-pharmaceutical company; i&i Prague, a bio-innovation center; Mama AI, specializing in artificial intelligence; and Santiago Chemicals.

The participation of Czech companies in the international trade fair is further bolstered by the support of CzechInvest, an agency dedicated to attracting foreign investments with high added value, particularly in HealthTech, BioTech, and medical devices. Matěj Zahradník, Director of Foreign Representation at CzechInvest in New York, highlights the unique opportunity that BIO International offers for Czech companies to expand their ideas on the East Coast of the USA. CzechInvest also provides support for domestic development through initiatives like the Technological Incubation project, facilitating entry into the American market.

Jan Hladík, Head of the Economic Section at the Embassy of the Czech Republic in Washington, D.C., acknowledges the United States as a leading global market for biotechnology services and products. He states, "The participation of Czech companies at BIO International opens up new opportunities for the expansion of Czech ideas."

The BIO International Convention, held annually in different cities across the United States, serves as a crucial platform for promoting innovation, scientific research, and the development of the biotechnology industry. The event features presentations, discussions, workshops, and exhibitions focused on the current state and future of biotechnology, enabling participants to establish new contacts, share knowledge, and discover potential business opportunities and partnerships.

Covering a wide range of topics, including therapeutic innovations, biotechnology entrepreneurship, regulatory issues, and human resource development, the BIO International Convention plays a vital role in information exchange, inspiration, and support for the growth of the biotechnology industry.